Cognate BioServices Competitors, Revenue and Alternatives
Estimated Revenue & Financials
- Cognate BioServices's estimated annual revenue is currently $43.6M per year.
- Cognate BioServices received $Undisclosed in venture funding in February 2018.
- Cognate BioServices's estimated revenue per employee is $155,000
- Cognate BioServices has 281 Employees.
- Cognate BioServices grew their employee count by 17% last year.
- Cognate BioServices currently has 21 job openings.
|Competitor Name||Revenue||Number of Employees||Employee Growth||Total Funding|
|American Gene T...||$4.7M||30||N/A||N/A|
What Is Cognate BioServices?
Cognate Bioservices is a fully-integrated contract bioservices organization providing the highest level of scientific and management expertise. Cognate provides full development and cGMP manufacturing services to companies and institutions engaged in the development of cell-based products. The combination of highly experienced staff, cGMP facilities and international track record makes Cognate one of the most experienced contract manufacturers of cell based products in the world today.keywords:N/A
Number of Employees
Employee Growth %
|Karim Khoury||Vp, Information Systems||Email Available|
|Lisa McClain-Moss||Director, Manufacturing||Email Available|
|Mike Stella||Chief Business Officer And Director||Email Available|
|Lori Noffsinger||Process Development Manager||Email Available|
|Sarah Campion||Director Of Product Development||Email Available|
|James Wilkerson||Director of Marketing|
|Kauser Hussain||Manager, Quality Control-Microbiology||Email Available|
|Jaehyung Yoon||Senior Vice President Finance And Strategy||Email Available|
|Michelle Gauvreau||Quality Assurance Manager||Email Available|
|Randy Elderkin||Director Of Validation||Email Available|
Cognate BioServices News
BALTIMORE and MEMPHIS, Tenn., Aug. 26, 2019 /PRNewswire/ -- Cognate BioServices, a leading contract development and manufacturing ...
EW Healthcare Partners has invested in Cognate BioServices. Financial terms weren't announced. Cognate BioServices is a contract ...
Cognate BioServices announced Monday, Aug. 26, that it closed a round of growth capital from New York-based EW Healthcare Partners.
Cognate BioServices Funding
|2018-02-21||$Undisclosed||Undisclosed||Tennenbaum Capital Partners, LLC||Article|